Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novo Nordisk A/S Class B (NOVOb)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
742.9 -5.9    -0.79%
18/05 - Closed. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Denmark
ISIN:  DK0060534915 
S/N:  1742564000
  • Volume: 1,387,000
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 737.2 - 755.0
Novo Nordisk B 742.9 -5.9 -0.79%

NOVOb Recent Sentiments

 
This page contains information on users’ sentiments for the Novo Nordisk A/S Class B stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 10, 2022 Dave Kearsley   751.6 -1.16%
May 05, 2022 Birk   796.4 May 09, 2022 @ 755.8 -5.10%
May 05, 2022 Ole Kjeldsen   793.6 -6.39%
May 04, 2022 Xu Zikai   798.8 May 04, 2022 @ 798.8 0.00%
May 02, 2022 Onur Durucan   815.5 -8.90%
Apr 28, 2022 FrankAB   765.3 -2.93%
Apr 21, 2022 Mujahid Mohamed A J   794.1 Apr 25, 2022 @ 778.1 -2.01%
Apr 19, 2022 Aurore Léauté   782.3 May 13, 2022 @ 749.1 -4.24%
Apr 07, 2022 Flemming Poulsen   801.5 Apr 29, 2022 @ 812.3 +1.35%
Apr 04, 2022 Birk   765.9 Apr 11, 2022 @ 826.0 -7.85%
Mar 01, 2022 Flemming Poulsen   698.8 Mar 25, 2022 @ 717.6 +2.69%
Feb 21, 2022 Helle Ramlyng   663.1 Mar 18, 2022 @ 741.6 +11.84%
Feb 08, 2022 Patrick Gendre   666.7 Feb 14, 2022 @ 643.1 -3.54%
Feb 07, 2022 Jarmo Välijärvi   644.2 Feb 14, 2022 @ 643.1 -0.17%
Feb 02, 2022 Guillaume de Marnix   694.3 Feb 07, 2022 @ 665.9 -4.09%
Feb 01, 2022 Juan Olmos   663.3 Feb 07, 2022 @ 665.9 +0.39%
Feb 01, 2022 TerribleInvestor   661.6 Feb 25, 2022 @ 672.9 +1.71%
Feb 01, 2022 Flemming Poulsen   663.1 Feb 25, 2022 @ 672.9 +1.48%
Jan 31, 2022 Steen Jensen   658.4 Feb 25, 2022 @ 672.9 +2.20%
Jan 27, 2022 Flemming Poulsen   643.3 Jan 29, 2022 @ 638.9 -0.68%
Jan 27, 2022 Lars Rigas   622.5 Feb 18, 2022 @ 661.8 -6.31%
Jan 25, 2022 Johnny Hansen   622.9 Feb 18, 2022 @ 661.8 -6.24%
Jan 24, 2022 Thomas Marinitsch   622.9 Jan 31, 2022 @ 656.1 +5.33%
Jan 21, 2022 Daniel Núñez   630.9 Feb 11, 2022 @ 655.0 +3.82%
Jan 20, 2022 Diego Rodil Rúa   631.4 Feb 11, 2022 @ 655.0 -3.74%
Jan 20, 2022 Kasper Lemke   625.7 Feb 11, 2022 @ 655.0 +4.68%
Jan 19, 2022 Øyvind Ludvigsen   625.8 Feb 11, 2022 @ 655.0 +4.67%
Jan 18, 2022 Annette Plesner   628.9 Feb 11, 2022 @ 655.0 +4.15%
Jan 17, 2022 Juan Olmos   629.6 Jan 24, 2022 @ 622.9 -1.06%
Jan 14, 2022 Alp Tankisi   637.6 Feb 04, 2022 @ 646.5 +1.40%
Jan 13, 2022 Tom White   653.6 Jan 17, 2022 @ 639.0 -2.23%
Jan 13, 2022 Bjarne Schøn   650.7 Feb 04, 2022 @ 646.5 -0.65%
Jan 12, 2022 Christian Krone   654.8 Feb 04, 2022 @ 646.5 -1.27%
Jan 12, 2022 Christian Krone   654.8 Feb 04, 2022 @ 646.5 -1.27%
Jan 12, 2022 Nuno Ferreira   660.8 Jan 17, 2022 @ 639.0 -3.30%
Jan 12, 2022 Peter Dam   654.9 Feb 04, 2022 @ 646.5 -1.28%
Jan 12, 2022 Luigi Nigro   660.3 Feb 04, 2022 @ 646.5 -2.09%
Jan 07, 2022 Bruno Airoldi   662.8 Jan 28, 2022 @ 638.9 +3.61%
Jan 06, 2022 Martin Stage Larsen   665.4 Jan 28, 2022 @ 638.9 -3.98%
Jan 06, 2022 Mikhail Gorbunov   665.8 Jan 10, 2022 @ 655.3 -1.58%
Jan 04, 2022 Ilan Kusiatin   687.6 Jan 28, 2022 @ 638.9 -7.08%
Jan 04, 2022 Per Nørgreen   686.7 Jan 28, 2022 @ 638.9 -6.96%
Jan 04, 2022 Diego Rodil Rúa   688.3 Jan 10, 2022 @ 655.3 -4.79%
Jan 04, 2022 Julio Antonio Ponce...   694.8 Jan 28, 2022 @ 638.9 -8.05%
Jan 03, 2022 Ole Kjeldsen   724.4 Jan 28, 2022 @ 638.9 -11.80%
Dec 22, 2021 Jens Christiansen   715.9 Jan 14, 2022 @ 624.7 -12.74%
Dec 21, 2021 Bogdan Zhe   694.0 Jan 14, 2022 @ 624.7 -9.99%
Dec 21, 2021 Aleksi Luukkanen   699.0 Jan 14, 2022 @ 624.7 -10.63%
Dec 20, 2021 Fritz Raser   681.5 Jan 14, 2022 @ 624.7 -8.33%
Dec 20, 2021 Negrevergne Pierre...   681.1 Dec 27, 2021 @ 728.1 -6.90%
More
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NOVOb Comments

Write your thoughts about Novo Nordisk A/S Class B
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Toby Brunt
Toby Brunt Apr 19, 2022 5:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Does anyone no of a particular reason that NOVO B is going so far down today? Is it profit taking before Q1 2022 results?
Reply
0 0
Report
Sandy SS
Sandy SS Feb 09, 2022 8:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
New Target 825 by EOM
Reply
1 0
Report
Sandy SS
Sandy SS Feb 09, 2022 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
New Target 825
Reply
0 0
Report
Terrible Investor
TerribleInvestor Nov 25, 2021 5:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Consolidating nicely for leg up to 850!🌟
Reply
1 0
Report
Ralf Adams
Ralf Adams Feb 11, 2021 4:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Results from clinical study just published in New England Journal of Medicine: Impressive new weight loss results for Semaglutide at only 2.4 mg once a week. Drug mimics the gut hormone glucagon-like peptide-1 (GLP-1) that is secreted by your gut after eating.
Reply
0 1
Report
Candy Man
Candy Man Jan 14, 2021 4:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Now is the time to buy - novo is very seasonal stock goes up the most in jan/feb.
Reply
1 0
Report
Carlos Andres
Carlos Andres Aug 25, 2020 4:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bullish??
Reply
2 0
Report
Carlos Andres
Carlos Andres Aug 25, 2020 4:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No. Funds are selling. Time to wait to go long...
Reply
0 0
Report
White Wizard
White Wizard May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Perfect opportunity to make short,,
Reply
0 1
Report
Wassim Khayata
Wassim Khayata May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
can you explain why please?
Reply
2 0
Report
Jeff Heimann
Jeff Heimann May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No explaning? 🤷
Reply
0 0
Report
Tommi Nuutinen
Tommi Nuutinen May 26, 2020 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
because he has no explanation. Novo nordisk is a soli long-term stock. I know a lot about opioid treatments, and methadon is changing to lipo-methadon, wich has really only one competitor on the global field. That competitor is Camurus AB with their product buvidol. I tecommend to all investors to buy and HOLD for these two companies, because there is no other options for a opioid-replacement-care, except Suboxone, and that is going to be replaced Lipo-methadon or Buvidol, at least here in Finland. Suboxone is manufactured for Indivor Inc, by Aquestive Therapeutics, if someone wants to do a little research.
Reply
2 0
Report
Hairol Azhar Abdul Kadir
Hairol Azhar Abdul Kadir Jan 19, 2020 2:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bullish sentiment.
Reply
0 0
Report
Petar Petrov
Petar Petrov Jul 15, 2019 2:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why is going so low???
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email